PubRank

J Heighway

Author PubWeight™ 41.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001 2.67
2 Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995 2.48
3 Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol 2003 1.94
4 Genetic predisposition to human lung cancer. Br J Cancer 1986 1.94
5 c-Ki-ras amplification in human lung cancer. Br J Cancer 1986 1.67
6 Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996 1.38
7 Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem 1997 1.17
8 Origin and prognostic value of circulating KRAS mutations in lung cancer patients. Cancer Lett 2007 1.17
9 Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br J Cancer 2005 1.07
10 Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum Mol Genet 1995 1.04
11 G1 control gene status is frequently altered in resectable non-small cell lung cancer. Int J Cancer 1997 1.04
12 Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene 1998 0.99
13 Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53. Br J Cancer 1994 0.98
14 Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 1998 0.97
15 S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. Br J Cancer 2004 0.97
16 METH-2 silencing and promoter hypermethylation in NSCLC. Br J Cancer 2004 0.96
17 N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS. Int J Cancer 1990 0.93
18 Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 1997 0.93
19 Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer 2001 0.90
20 Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patient. Hum Genet 1995 0.89
21 Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. Br J Cancer 2002 0.89
22 An expectation-maximization algorithm for the analysis of allelic expression imbalance. Am J Hum Genet 2006 0.89
23 Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults. Oncogene 1998 0.88
24 Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Br J Cancer 1997 0.87
25 Physical localisation of the breakpoints of a constitutional translocation t(5;6)(q21;q21) in a child with bilateral Wilms' tumour. J Med Genet 1997 0.86
26 Fibroblasts from Li-Fraumeni patients are resistant to low dose-rate irradiation. Int J Radiat Biol 1996 0.85
27 Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancer. Oncogene 1998 0.84
28 High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor. Br J Cancer 1996 0.83
29 Anonymous genomic fragment co-amplified with c-Ki-ras 2 detects frequent polymorphism (pK42). Nucleic Acids Res 1986 0.82
30 Constitutional frequencies of c-Ha-ras alleles in patients with different types of lung cancer. Br J Cancer 1990 0.79
31 No defect in G1/S cell cycle arrest in irradiated Li-Fraumeni lymphoblastoid cell lines. Br J Cancer 1996 0.79
32 Identification of individuals at risk: cytogenetic and molecular methods. Prog Clin Biol Res 1986 0.79
33 Isolation of a human genomic fragment, co-amplified with c-Ki-ras, that affects plasmid supercoiling in E. coli. Nucleic Acids Res 1987 0.78
34 Mapping of gene loci in the Q13-Q15 region of chromosome 12. Chromosome Res 1995 0.78
35 A cell line from Wilms' tumour with deletion in short arm of chromosome II. Int J Cancer 1987 0.78
36 Genomic structure and expression profile of LPHH1, a 7TM gene variably expressed in breast cancer cell lines. Biochim Biophys Acta 2000 0.78
37 Constitutional frequency of rare alleles of c-Ha-ras in breast cancer patients. Br J Cancer 1988 0.77
38 p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer. Int J Oncol 2000 0.76
39 A strategy for the rapid isolation of new PCR based DNA polymorphisms. J Med Genet 1992 0.75
40 Alveolar rhabdomyosarcoma - primary and recurrent metastatic tumor has chromosomal translocation t(2-13)(q37-q14), amplified N-myc and is tumorigenic in nude-mice. Int J Oncol 1992 0.75
41 A polymerase chain reaction-based method for the detection of trisomy 12 in B chronic lymphocytic leukaemia. Br J Haematol 1993 0.75